ABBV:VIE
AbbVie Common Stock
€231.20
arrow_downward
-0.69%(-1.60) 1D
Oct 1, 3:30:19 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
€231.60
High
€231.90
Low
€231.00
Mkt. cap
461.80B
Avg. vol.
2.00
Volume
0.00
52-wk high
€234.90
52-wk low
€164.30
No. of employees
57K
Open
€231.60
High
€231.90
Low
€231.00
Mkt. cap
461.80B
Avg. vol.
2.00
Volume
0.00
52-wk high
€234.90
52-wk low
€164.30
No. of employees
57K
News stories
From web sources and news partners
Investing.com India
·
4 minutes ago
AbbVie reports long-term vitiligo data for RINVOQ at EADV By Investing.com
Investing News Network
·
14 minutes ago
AbbVie to Host Third-Quarter 2026 Earnings Conference Call
The Globe and Mail
·
44 minutes ago
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell?
Pluang
·
1 hour ago
AbbVie to release Q3 2026 earnings on Oct 30 be...
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com